Daisuke Ikeda

16PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 26, 2025
Efficacy and relapse profiles of Pola-R-CHP versus R-CHOP in previously untreated diffuse large B-cell lymphoma: A multicentre real-world study.

Toshiki Terao, Isao Yoshida, Hiroki Kobayashi

|Oct 08, 2025
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia.

Mitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa

|Sep 04, 2025
Late-Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T-Cell Therapy.

Daisuke Ikeda, Tomohiro Nawada, Takumi Kondo

|Oct 23, 2024
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma.

Daisuke Ikeda, Shuichi Aikawa, Chiho Misono

|Dec 27, 2023
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma.

Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura

|Jul 03, 2023
Safety and efficacy of venetoclax for acute myeloid leukaemia in real-world clinical practice.

Ami Fukumoto, Kentaro Narita, Daisuke Ikeda

Pageof 3

Frequent Collaborators

10 joint publications

Kosei Matsue

8 joint publications

Kentaro Narita

6 joint publications

Mitsuaki Oura

4 joint publications

Toshiki Terao